Our Mission
To ensure that our biomimetic regenerative endocrine cellular and engineered endocrine tissue therapies have their greatest impact by resolving human endocrine gland dysfunction and life-long dependence on exogenous synthetic hormone replacement therapy.
Indications
Parathyroid, Adrenal, Thyroid
Business Model
Multifaceted model with multiple revenue streams.
Our Mission
To ensure that our biomimetic regenerative endocrine cellular and engineered endocrine tissue therapies have their greatest impact by resolving human endocrine gland dysfunction and life-long dependence on exogenous synthetic hormone replacement therapy.
About Us
Fortuna Therapeutics is a biotechnology and biopharmaceutical company focused on endocrine regenerative cellular and engineered endocrine tissue therapies for parathyroid, thyroid and adrenal disease-related endocrine dysfunctions. Our team, consisting of highly experienced executives, physician-scientists, stem-cell and tissue engineering experts, and scientific advisors, works with urgency to develop additional therapies for patients while upholding the highest standards of quality.
Innovation
Fortuna is poised to become a leader in endocrine regeneration by utilizing stem cell technology, unique properties of microgravity, in-space endocrine organoid growth and tissue engineering, and biopharmaceutic manufacturing in low-earth orbit for terrestrial and space applications to improve human health.
Our Technology
Indications
- Parathyroid
- Adrenal
- Thyroid
Business Model
Multifaceted model with multiple revenuestreams